Drugs for cardiovascular disease in India: perspectives of pharmaceutical executives and government officials on access and development-a qualitative analysis.

Newman, Charles; Ajay, Vamadevan S; Srinivas, Ravi; Bhalla, Sandeep; Prabhakaran, Dorairaj; Banerjee, Amitava; (2016) Drugs for cardiovascular disease in India: perspectives of pharmaceutical executives and government officials on access and development-a qualitative analysis. Journal of pharmaceutical policy and practice, 9 (1). p. 16. ISSN 2052-3211 DOI: https://doi.org/10.1186/s40545-016-0065-7

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1186/s40545-016-0065-7

Abstract

Share

Download

Filename: Drugs for cardiovascular disease in India perspectives of pharmaceutical executives and government officials on access and d.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar